APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccination

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oral Vaccination Industry Research Report 2026

22 December 2025135 pages

Choose your research edition.

Industry ResearchOral Vaccination Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccination Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Oral Vaccination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccination Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccination Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral Vaccination market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oral Vaccination is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oral Vaccination is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oral Vaccination include Lanzhou Institute, Tiantan Biological, Sanofi, Merck, Shanghai United Cell, GSK, Valneva, Vabiotech and Serum Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oral Vaccination market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral Vaccination Market by Company

Lanzhou Institute

Tiantan Biological

Sanofi

Merck

Shanghai United Cell

GSK

Valneva

Vabiotech

Serum Institute

Panacea Biotec Ltd

Halfkin Bio-Pharmaceuticals

EuBiologics

Emergent BioSolutions

Bio-Med

Bibcol

Oral Vaccination Segment by Type

Rotavirus Vaccine

Oral Polio Vaccine

Cholera Vaccine

Other

Oral Vaccination Segment by Application

Public

Private

Oral Vaccination Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccination and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccination.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral Vaccination manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral Vaccination by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Vaccination Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral Vaccination Sales (k units) of Manufacturers (2021-2026) Table 7. Global Oral Vaccination Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral Vaccination Revenue of Manufacturers (2021-2026) Table 9. Global Oral Vaccination Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral Vaccination Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Oral Vaccination Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral Vaccination, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral Vaccination, Product Type & Application Table 14. Global Oral Vaccination Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral Vaccination by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Lanzhou Institute Company Information Table 19. Lanzhou Institute Business Overview Table 20. Lanzhou Institute Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Lanzhou Institute Oral Vaccination Product Portfolio Table 22. Lanzhou Institute Recent Developments Table 23. Tiantan Biological Company Information Table 24. Tiantan Biological Business Overview Table 25. Tiantan Biological Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Tiantan Biological Oral Vaccination Product Portfolio Table 27. Tiantan Biological Recent Developments Table 28. Sanofi Company Information Table 29. Sanofi Business Overview Table 30. Sanofi Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Sanofi Oral Vaccination Product Portfolio Table 32. Sanofi Recent Developments Table 33. Merck Company Information Table 34. Merck Business Overview Table 35. Merck Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Merck Oral Vaccination Product Portfolio Table 37. Merck Recent Developments Table 38. Shanghai United Cell Company Information Table 39. Shanghai United Cell Business Overview Table 40. Shanghai United Cell Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Shanghai United Cell Oral Vaccination Product Portfolio Table 42. Shanghai United Cell Recent Developments Table 43. GSK Company Information Table 44. GSK Business Overview Table 45. GSK Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. GSK Oral Vaccination Product Portfolio Table 47. GSK Recent Developments Table 48. Valneva Company Information Table 49. Valneva Business Overview Table 50. Valneva Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Valneva Oral Vaccination Product Portfolio Table 52. Valneva Recent Developments Table 53. Vabiotech Company Information Table 54. Vabiotech Business Overview Table 55. Vabiotech Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Vabiotech Oral Vaccination Product Portfolio Table 57. Vabiotech Recent Developments Table 58. Serum Institute Company Information Table 59. Serum Institute Business Overview Table 60. Serum Institute Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Serum Institute Oral Vaccination Product Portfolio Table 62. Serum Institute Recent Developments Table 63. Panacea Biotec Ltd Company Information Table 64. Panacea Biotec Ltd Business Overview Table 65. Panacea Biotec Ltd Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Panacea Biotec Ltd Oral Vaccination Product Portfolio Table 67. Panacea Biotec Ltd Recent Developments Table 68. Halfkin Bio-Pharmaceuticals Company Information Table 69. Halfkin Bio-Pharmaceuticals Business Overview Table 70. Halfkin Bio-Pharmaceuticals Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio Table 72. Halfkin Bio-Pharmaceuticals Recent Developments Table 73. EuBiologics Company Information Table 74. EuBiologics Business Overview Table 75. EuBiologics Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. EuBiologics Oral Vaccination Product Portfolio Table 77. EuBiologics Recent Developments Table 78. Emergent BioSolutions Company Information Table 79. Emergent BioSolutions Business Overview Table 80. Emergent BioSolutions Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Emergent BioSolutions Oral Vaccination Product Portfolio Table 82. Emergent BioSolutions Recent Developments Table 83. Bio-Med Company Information Table 84. Bio-Med Business Overview Table 85. Bio-Med Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Bio-Med Oral Vaccination Product Portfolio Table 87. Bio-Med Recent Developments Table 88. Bibcol Company Information Table 89. Bibcol Business Overview Table 90. Bibcol Oral Vaccination Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Bibcol Oral Vaccination Product Portfolio Table 92. Bibcol Recent Developments Table 93. Global Oral Vaccination Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Oral Vaccination Sales by Region (2021-2026) & (k units) Table 95. Global Oral Vaccination Sales Market Share by Region (2021-2026) Table 96. Global Oral Vaccination Sales by Region (2027-2032) & (k units) Table 97. Global Oral Vaccination Sales Market Share by Region (2027-2032) Table 98. Global Oral Vaccination Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Oral Vaccination Revenue Market Share by Region (2021-2026) Table 100. Global Oral Vaccination Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Oral Vaccination Revenue Market Share by Region (2027-2032) Table 102. North America Oral Vaccination Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Oral Vaccination Sales by Country (2021-2026) & (k units) Table 104. North America Oral Vaccination Sales by Country (2027-2032) & (k units) Table 105. North America Oral Vaccination Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Oral Vaccination Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Oral Vaccination Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Oral Vaccination Sales by Country (2021-2026) & (k units) Table 109. Europe Oral Vaccination Sales by Country (2027-2032) & (k units) Table 110. Europe Oral Vaccination Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Oral Vaccination Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Oral Vaccination Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Oral Vaccination Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Oral Vaccination Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Oral Vaccination Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Oral Vaccination Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Oral Vaccination Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Oral Vaccination Sales by Country (2021-2026) & (k units) Table 119. South America Oral Vaccination Sales by Country (2027-2032) & (k units) Table 120. South America Oral Vaccination Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Oral Vaccination Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Oral Vaccination Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Oral Vaccination Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Oral Vaccination Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Oral Vaccination Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Oral Vaccination Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Oral Vaccination Sales by Type (2021-2026) & (k units) Table 128. Global Oral Vaccination Sales by Type (2027-2032) & (k units) Table 129. Global Oral Vaccination Sales Market Share by Type (2021-2026) Table 130. Global Oral Vaccination Sales Market Share by Type (2027-2032) Table 131. Global Oral Vaccination Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Oral Vaccination Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Oral Vaccination Revenue Market Share by Type (2021-2026) Table 134. Global Oral Vaccination Revenue Market Share by Type (2027-2032) Table 135. Global Oral Vaccination Price by Type (2021-2026) & (US$/unit) Table 136. Global Oral Vaccination Price by Type (2027-2032) & (US$/unit) Table 137. Global Oral Vaccination Sales by Application (2021-2026) & (k units) Table 138. Global Oral Vaccination Sales by Application (2027-2032) & (k units) Table 139. Global Oral Vaccination Sales Market Share by Application (2021-2026) Table 140. Global Oral Vaccination Sales Market Share by Application (2027-2032) Table 141. Global Oral Vaccination Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Oral Vaccination Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Oral Vaccination Revenue Market Share by Application (2021-2026) Table 144. Global Oral Vaccination Revenue Market Share by Application (2027-2032) Table 145. Global Oral Vaccination Price by Application (2021-2026) & (US$/unit) Table 146. Global Oral Vaccination Price by Application (2027-2032) & (US$/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Oral Vaccination Distributors List Table 150. Oral Vaccination Customers List Table 151. Oral Vaccination Industry Trends Table 152. Oral Vaccination Industry Drivers Table 153. Oral Vaccination Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral Vaccination Product Image Figure 5. Global Oral Vaccination Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral Vaccination Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral Vaccination Sales (2021-2032) & (k units) Figure 8. Global Oral Vaccination Average Price (US$/unit) & (2021-2032) Figure 9. Rotavirus Vaccine Product Image Figure 10. Oral Polio Vaccine Product Image Figure 11. Cholera Vaccine Product Image Figure 12. Other Product Image Figure 13. Public Product Image Figure 14. Private Product Image Figure 15. Global Oral Vaccination Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Oral Vaccination, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Oral Vaccination Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Oral Vaccination Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Oral Vaccination Sales by Region in 2025 Figure 21. Global Oral Vaccination Revenue by Region in 2025 Figure 22. North America Oral Vaccination Market Size by Country in 2025 Figure 23. North America Oral Vaccination Sales Market Share by Country (2021-2032) Figure 24. North America Oral Vaccination Revenue Market Share by Country (2021-2032) Figure 25. United States Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Oral Vaccination Market Size by Country in 2025 Figure 29. Europe Oral Vaccination Sales Market Share by Country (2021-2032) Figure 30. Europe Oral Vaccination Revenue Market Share by Country (2021-2032) Figure 31. Germany Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Oral Vaccination Market Size by Country in 2025 Figure 42. Asia Pacific Oral Vaccination Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Oral Vaccination Revenue Market Share by Country (2021-2032) Figure 44. China Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Oral Vaccination Market Size by Country in 2025 Figure 53. South America Oral Vaccination Sales Market Share by Country (2021-2032) Figure 54. South America Oral Vaccination Revenue Market Share by Country (2021-2032) Figure 55. Brazil Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Oral Vaccination Market Size by Country in 2025 Figure 59. Middle East and Africa Oral Vaccination Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Oral Vaccination Revenue Market Share by Country (2021-2032) Figure 61. Egypt Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Oral Vaccination Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Oral Vaccination Sales Market Share by Type (2021-2032) Figure 67. Global Oral Vaccination Revenue Market Share by Type (2021-2032) Figure 68. Global Oral Vaccination Price (US$/unit) by Type (2021-2032) Figure 69. Global Oral Vaccination Sales Market Share by Application (2021-2032) Figure 70. Global Oral Vaccination Revenue Market Share by Application (2021-2032) Figure 71. Global Oral Vaccination Price (US$/unit) by Application (2021-2032) Figure 72. Oral Vaccination Value Chain Figure 73. Oral Vaccination Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Oral Vaccination Industry Opportunities and Challenges

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Oral Polio Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Public
  • Private
Companies covered
  • Lanzhou Institute
  • Tiantan Biological
  • Sanofi
  • Merck
  • Shanghai United Cell
  • GSK
  • Valneva
  • Vabiotech
  • Serum Institute
  • Panacea Biotec Ltd
  • Halfkin Bio-Pharmaceuticals
  • EuBiologics
  • Emergent BioSolutions
  • Bio-Med
  • Bibcol

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral Vaccination Market Size (2021-2032)
  4. 2.2.2 Global Oral Vaccination Sales (2021-2032)
  5. 2.2.3 Global Oral Vaccination Market Average Price (2021-2032)
  6. 2.3 Oral Vaccination by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Rotavirus Vaccine
  9. 2.3.3 Oral Polio Vaccine
  10. 2.3.4 Cholera Vaccine
  11. 2.3.5 Other
  12. 2.4 Oral Vaccination by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Public
  15. 2.4.3 Private
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral Vaccination Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral Vaccination Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Oral Vaccination Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral Vaccination Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral Vaccination Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral Vaccination, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral Vaccination, Product Type & Application
  8. 3.8 Global Manufacturers of Oral Vaccination, Established Date
  9. 3.9 Global Oral Vaccination Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Lanzhou Institute
  2. 4.1.1 Lanzhou Institute Company Information
  3. 4.1.2 Lanzhou Institute Business Overview
  4. 4.1.3 Lanzhou Institute Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Lanzhou Institute Oral Vaccination Product Portfolio
  6. 4.1.5 Lanzhou Institute Recent Developments
  7. 4.2 Tiantan Biological
  8. 4.2.1 Tiantan Biological Company Information
  9. 4.2.2 Tiantan Biological Business Overview
  10. 4.2.3 Tiantan Biological Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Tiantan Biological Oral Vaccination Product Portfolio
  12. 4.2.5 Tiantan Biological Recent Developments
  13. 4.3 Sanofi
  14. 4.3.1 Sanofi Company Information
  15. 4.3.2 Sanofi Business Overview
  16. 4.3.3 Sanofi Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sanofi Oral Vaccination Product Portfolio
  18. 4.3.5 Sanofi Recent Developments
  19. 4.4 Merck
  20. 4.4.1 Merck Company Information
  21. 4.4.2 Merck Business Overview
  22. 4.4.3 Merck Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Merck Oral Vaccination Product Portfolio
  24. 4.4.5 Merck Recent Developments
  25. 4.5 Shanghai United Cell
  26. 4.5.1 Shanghai United Cell Company Information
  27. 4.5.2 Shanghai United Cell Business Overview
  28. 4.5.3 Shanghai United Cell Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shanghai United Cell Oral Vaccination Product Portfolio
  30. 4.5.5 Shanghai United Cell Recent Developments
  31. 4.6 GSK
  32. 4.6.1 GSK Company Information
  33. 4.6.2 GSK Business Overview
  34. 4.6.3 GSK Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GSK Oral Vaccination Product Portfolio
  36. 4.6.5 GSK Recent Developments
  37. 4.7 Valneva
  38. 4.7.1 Valneva Company Information
  39. 4.7.2 Valneva Business Overview
  40. 4.7.3 Valneva Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Valneva Oral Vaccination Product Portfolio
  42. 4.7.5 Valneva Recent Developments
  43. 4.8 Vabiotech
  44. 4.8.1 Vabiotech Company Information
  45. 4.8.2 Vabiotech Business Overview
  46. 4.8.3 Vabiotech Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Vabiotech Oral Vaccination Product Portfolio
  48. 4.8.5 Vabiotech Recent Developments
  49. 4.9 Serum Institute
  50. 4.9.1 Serum Institute Company Information
  51. 4.9.2 Serum Institute Business Overview
  52. 4.9.3 Serum Institute Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Serum Institute Oral Vaccination Product Portfolio
  54. 4.9.5 Serum Institute Recent Developments
  55. 4.10 Panacea Biotec Ltd
  56. 4.10.1 Panacea Biotec Ltd Company Information
  57. 4.10.2 Panacea Biotec Ltd Business Overview
  58. 4.10.3 Panacea Biotec Ltd Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Panacea Biotec Ltd Oral Vaccination Product Portfolio
  60. 4.10.5 Panacea Biotec Ltd Recent Developments
  61. 4.11 Halfkin Bio-Pharmaceuticals
  62. 4.11.1 Halfkin Bio-Pharmaceuticals Company Information
  63. 4.11.2 Halfkin Bio-Pharmaceuticals Business Overview
  64. 4.11.3 Halfkin Bio-Pharmaceuticals Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio
  66. 4.11.5 Halfkin Bio-Pharmaceuticals Recent Developments
  67. 4.12 EuBiologics
  68. 4.12.1 EuBiologics Company Information
  69. 4.12.2 EuBiologics Business Overview
  70. 4.12.3 EuBiologics Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 EuBiologics Oral Vaccination Product Portfolio
  72. 4.12.5 EuBiologics Recent Developments
  73. 4.13 Emergent BioSolutions
  74. 4.13.1 Emergent BioSolutions Company Information
  75. 4.13.2 Emergent BioSolutions Business Overview
  76. 4.13.3 Emergent BioSolutions Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Emergent BioSolutions Oral Vaccination Product Portfolio
  78. 4.13.5 Emergent BioSolutions Recent Developments
  79. 4.14 Bio-Med
  80. 4.14.1 Bio-Med Company Information
  81. 4.14.2 Bio-Med Business Overview
  82. 4.14.3 Bio-Med Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bio-Med Oral Vaccination Product Portfolio
  84. 4.14.5 Bio-Med Recent Developments
  85. 4.15 Bibcol
  86. 4.15.1 Bibcol Company Information
  87. 4.15.2 Bibcol Business Overview
  88. 4.15.3 Bibcol Oral Vaccination Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bibcol Oral Vaccination Product Portfolio
  90. 4.15.5 Bibcol Recent Developments
5 Global Oral Vaccination Market Scenario by Region
  1. 5.1 Global Oral Vaccination Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral Vaccination Sales by Region: 2021-2032
  3. 5.2.1 Global Oral Vaccination Sales by Region: 2021-2026
  4. 5.2.2 Global Oral Vaccination Sales by Region: 2027-2032
  5. 5.3 Global Oral Vaccination Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral Vaccination Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral Vaccination Revenue by Region: 2027-2032
  8. 5.4 North America Oral Vaccination Market Facts & Figures by Country
  9. 5.4.1 North America Oral Vaccination Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral Vaccination Sales by Country (2021-2032)
  11. 5.4.3 North America Oral Vaccination Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Oral Vaccination Market Facts & Figures by Country
  16. 5.5.1 Europe Oral Vaccination Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Oral Vaccination Sales by Country (2021-2032)
  18. 5.5.3 Europe Oral Vaccination Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Oral Vaccination Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Oral Vaccination Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Oral Vaccination Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Oral Vaccination Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Oral Vaccination Market Facts & Figures by Country
  41. 5.7.1 South America Oral Vaccination Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Oral Vaccination Sales by Country (2021-2032)
  43. 5.7.3 South America Oral Vaccination Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Oral Vaccination Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Oral Vaccination Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Oral Vaccination Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Oral Vaccination Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Oral Vaccination Sales by Type (2021-2032)
  2. 6.1.1 Global Oral Vaccination Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Oral Vaccination Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral Vaccination Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral Vaccination Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral Vaccination Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral Vaccination Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral Vaccination Sales by Application (2021-2032)
  2. 7.1.1 Global Oral Vaccination Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Oral Vaccination Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral Vaccination Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral Vaccination Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral Vaccination Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral Vaccination Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral Vaccination Value Chain Analysis
  2. 8.1.1 Oral Vaccination Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral Vaccination Production Mode & Process
  5. 8.2 Oral Vaccination Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral Vaccination Distributors
  8. 8.2.3 Oral Vaccination Customers
9 Global Oral Vaccination Analyzing Market Dynamics
  1. 9.1 Oral Vaccination Industry Trends
  2. 9.2 Oral Vaccination Industry Drivers
  3. 9.3 Oral Vaccination Industry Opportunities and Challenges
  4. 9.4 Oral Vaccination Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst